Astec LifeSciences share news and announcements
NSE: ASTECBSE: 533138Fertilizers & AgrochemicalsSmall Cap
Last close ₹663.70down ₹5.50 (0.82%)BSE ₹664.30
Share price at the NSE close on 23 Oct 2026. Previous close ₹669.20.
52-week range of traded prices to 23 Oct 2026
₹513.40Low, 23 Mar 2026₹941.75High, 26 Nov 2025
- Next results date: the board meets on 26 Oct 2026 to consider: financial results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹1,479 Cr1,284th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 27 Apr 2026
- 3.8
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 31 Jul 2026
- −21.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 31 Jul 2026
- −4.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 27 Apr 2026
- 1.15
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 33,48432.9% delivered
Astec LifeSciences share news and announcements
801 announcements, routine notices left out, newest first. Page 16 of 17.
May 2012
4 May · Results
Company has opted the option to submit audited financial results for the entire Financial Year 2011-12. The Company has further informed the Exchange that the Company will not file financial results for the quarter ended on March 31, 2012.
Mar 2012
Feb 2012
24 Feb · Board meeting
To consider and approve following items of agenda: 1) To increase Authorized Capital of the Company from Rs. 17,00,00,000/- (Rupees Seventeen Crores Only) to Rs.20,00,00,000/- (Rupees Twenty Crores Only) by creation of Rs.3,00,00,000/- (Rupees Three Crores Only) divided into 30,00,000 (Thirty Lacs) Equity Shares of Rs.10/- (Rupees Ten Only) each, 2) To approve issue of Warrants Convertible into Equity Shares to Promoters/Promoter Group on preferential basis. 3) To Constitute "Compensation Committee" and to discuss "ASTEC Employees Stock Option Plan, 2012". 4) To approve Alteration of Memorandum & Articles of Association to give effect to item nos.1,2&3. 5) To authorize Director of the Company or Company Secretary, for convening Extra Ordinary General Meeting for obtaining consent of members of the Company's for item nos. 1,2,3 & 4 above. 6) Any other matter with the permission of Chair.6 Feb · Board meeting
To consider and approve amongst other items of agenda, the Unaudited Financial Results of the Company for the quarter ended December 31, 2011 after these results are reviewed by the Audit Committee.
Jan 2012
4 Jan · Board meeting
Board of Director of the Company at its meeting held on January 04, 2012 subject to the approval of the shareholders appointed Mr. Janak Jaganath Rawal as Whole Time Director & re-appointed Mr. Ashok V. Hiremath as Chairman & Managing Director of the Company for a period of Three years from January 20, 2012. The approval of the shareholders would be obtained through Postal Ballot.2 Jan · Board meeting
To transact the following business: 1)Appointment of Mr. Janak Rawal as Whole Time Director subject to the approval of members. 2) Reappointment of Mr. Ashok V. Hiremath as Chairman & Managing Director subject to the approval of members.3) Any other business with the permission of Chair.
Dec 2011
Nov 2011
4 Nov · Board meeting
To consider and approve amongst other items of agenda, the Unaudited Financial Results of the Company for the quarter ended September 30, 2011 after these results are reviewed by the Audit Committee.
Sep 2011
12 Sep · Management
Mr. Ramakant Lad have been appointed as Chief Financial Officer of the Company with effect from September 03, 2011 in place of Mr. Vijaykumar Jain, who has resigned on the same date.
Aug 2011
11 Aug · Meeting
Annual General Meeting of the Company will be held on September 23, 2011. The Register of Members and the Share Transfer Books of the Company will remain closed from September 19, 2011 to September 23, 2011 (both days inclusive) for the purpose of Annual General Meeting and Dividend Payment.1 Aug · Board meeting
To consider and approve amongst other items of agenda, the Unaudited Financial Results of the Company for the quarter ended June 30, 2011 after these results are reviewed by the Audit Committee.
May 2011
30 May · Dividend
Board of Directors of the Company at its meeting held on May 27, 2011 have recommended a dividend of 50 paisey per share (i.e. 5% on the face value of Rs. 10/- each) for the approval of the Shareholders at the ensuing Annual General Meeting.13 May · Board meeting
Inter alia, to transact the following business : (1) To consider and approve the Audited Annual Accounts for the year ended March 31, 2011, after these accounts are reviewed by Audit Committee; (2) To recommend dividend on the Equity shares, if any.
Apr 2011
13 Apr · Results
Company will declare and publish Audited Financial Results for the entire financial year ended March 31, 2011 within a period of sixty (60) days from the end of financial year i.e. on or before May 30, 2011 in place of Unaudited quarterly financial results for the quarter ended March 31, 2011, as per SEBI guidelines.
Feb 2011
15 Feb · Address Change
Company has shifted its registered Office from 5, 5-A, 4th Floor, Kamanwala Chambers, Sir P. M. Road, Fort, Mumbai-400001 to Elite Square, 7th Floor, 274, Perin Nariman Street, Fort, Mumbai-400001 with effect from February 16, 2011.
Jan 2011
27 Jan · Board meeting
To consider and approve amongst other items of agenda, the Unaudited Financial Results of the Company for the quarter ended December 31, 2010 after these results are reviewed by the Audit Committee.
Dec 2010
1 Dec · Updates
Company has formed a 100% subsidiary company namely M/s. Astec Crop Care Private Limited with the main object to start the business of trading in Agrochemicals & Pesticides formulation to sell in local as well as in export market with its own brand name. Initially, this Company proposes to launch its product in the state of Gujarat, Karnataka & Maharashtra. Company has also appointed a dedicated team to take the new venture ahead.
Nov 2010
2 Nov · Board meeting
To consider and approve amongst other items of agenda, the Unaudited Financial Results of the Company for the quarter ended September 30, 2010 after these results are reviewed by the Audit Committee.
Sep 2010
Aug 2010
24 Aug · Meeting
Members at the Annual General Meeting of the Company held on August 23, 2010, have passed the following resolutions unanimously: 1) Adoption of the Audited Balance-Sheet as at March 31, 2010 and the Profit and Loss Account for the financial year ended on that date together with the Reports of the Auditors' and Directors' thereon. 2) Declaration of Final dividend for the FY 2009-2010 @ 10%. 3) Re-appointment of Shri. Laxmikant Kabra, Director of the Company, retiring by rotation and being eligible for reappointment, as Director of the Company. 4) Re-appointment of Dr. P. L. Tiwari, Director of the Company, retiring by rotation and being eligible for reappointment, as Director of the Company. 5) Re-appointment of M/s. P. M. Kathariya & Co., Chartered Accountants, to hold office from the conclusion of this Annual General Meeting until the conclusion of the next Annual General Meeting and authorizing the Board of Directors to fix their remuneration.23 Aug · Updates
The "Company has acquired land in MIDC Mahad area admeasuring 40000 sq.mtrs. (10 acres) with a view to set up additional manufacturing facilities on the new site. This site is located few kilometers from our existing facilities at Mahad. Proximity to our existing site will make it convenient to manage with our existing infrastructure and to optimize cost efficiency. The proposed expansion at the new site will be over and above the expansion at our existing sites".
Jul 2010
26 Jul · Board meeting
To consider and approve amongst other items of agenda, the Unaudited Financial Results of the Company for the quarter ended June 30, 2010 after these results are reviewed by the Audit Committee.21 Jul · Meeting
Register of Members and Share Transfer Books will remain closed from August 16, 2010 to August 23, 2010 (both days inclusive) for the purpose of Dividend Payment and Annual General Meeting (AGM) to be held on August 23, 2010.
Jun 2010
21 Jun · Updates
Company has entered into a long term mutually exclusive confidential contract to supply a herbicide to a multinational agrochemical major. The signing of this agreement will have a substantial positive impact on the company's agrochemical business in coming years.
May 2010
24 May · Change in Company Secretary
Board has appointed Mr. Vikas R. Chomal as Company Secretary and Compliance Officer of the Company consequent upon resignation of Ms. Nikita Jain as Company Secretary and Compliance Officer.24 May · Dividend
Board of Directors at its Meeting held on May 24, 2010 have recommended a dividend of Re. 1 per share (i.e. 10% on the face value of Rs. 10/- each) for the approval of the Shareholders at the ensuing Annual General Meeting.10 May · Board meeting
Inter alia, to transact the following business : (1) To consider and approve the Audited Annual Accounts for the year ended March 31, 2010; (2) To recommend Dividend on the Equity shares, if any.
Apr 2010
15 Apr · Results
Company will declare and publish Audited Financial Results (Consolidated as well as Standalone) for the entire financial year ended March 31, 2010 within a period of 60 days from the end of financial year i.e. on or before May 30, 2010 in place of Unaudited quarterly financial results for the quarter ended March 31, 2010, as per SEBI guidelines.5 Apr · Results
Company will declare and publish Audited Financial Results (Consolidated as well as Standalone) for the entire financial year March 31, 2010 within a period of three months from the end of financial year i.e. on or before June 30, 2010 in place of Unaudited quarterly financial results for the quarter ended March 31, 2010.
Mar 2010
22 Mar · Updates
'Excellence Award' for Astec LifeSciences Limited and 'Udyog Rattan Award' for Mr. Ashok V. Hiremath, Chairman & Managing Director. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jan 2010
28 Jan · Utilisation of Funds
Vide notes to Accounts in the unaudited financial results for the quarter ended December 31, 2009 (taken on record by the Board of Directors of the Company at its meeting held on January 28, 2010) that Statement of utilisation of proceeds from Public Issue as on December 31, 2009. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.19 Jan · Board meeting
To consider, inter alia, Unaudited Financial Results of the Company for the quarter ended December 31, 2009. Further the Company has informed that the Meeting of Audit Committee for consideration of accounts is scheduled to be held on January 28, 2010 before the Board Meeting.